» Articles » PMID: 27880851

Diagnostic Utility of Pleural Fluid Cell Block Versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis

Overview
Journal PLoS One
Date 2016 Nov 24
PMID 27880851
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some trials recently demonstrated the benefit of targeted treatment for malignant disease; therefore, adequate tissues are needed to detect the targeted gene. Pleural biopsy using flex-rigid pleuroscopy and pleural effusion cell block analysis are both useful for diagnosis of malignancy and obtaining adequate samples. The purpose of our study was to compare the diagnostic utility between the two methods among patients with malignant pleural disease with effusion.

Methods: Data from patients who underwent flex-rigid pleuroscopy for diagnosis of pleural effusion suspicious for malignancy at the National Cancer Center Hospital, Japan between April 2011 and June 2014 were retrospectively reviewed. All procedures were performed under local anesthesia. At least 150 mL of pleural fluid was collected by pleuroscopy, followed by pleural biopsies from the abnormal site.

Results: Thirty-five patients who were finally diagnosed as malignant pleural disease were included in this study. Final diagnoses of malignancy were 24 adenocarcinoma, 1 combined adeno-small cell carcinoma, and 7 malignant pleural mesothelioma (MPM), and 3 metastatic breast cancer. The diagnostic yield was significantly higher by pleural biopsy than by cell block [94.2% (33/35) vs. 71.4% (25/35); p = 0.008]. All patients with positive results on cell block also had positive results on pleural biopsy. Eight patients with negative results on cell block had positive results on pleural biopsy (lung adenocarcinoma in 4, sarcomatoid MPM in 3, and metastatic breast cancer in 1). Two patients with negative results on both cell block and pleural biopsy were diagnosed was sarcomatoid MPM by computed tomography-guided needle biopsy and epithelioid MPM by autopsy.

Conclusion: Pleural biopsy using flex-rigid pleuroscopy was efficient in the diagnosis of malignant pleural diseases. Flex-rigid pleuroscopy with pleural biopsy and pleural effusion cell block analysis should be considered as the initial diagnostic approach for malignant pleural diseases presenting with effusion.

Citing Articles

Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.

Wang K, Hu X, Chen Y, Yi X, Han X, Zhu D Clin Respir J. 2023; 18(1):e13705.

PMID: 37775991 PMC: 10807626. DOI: 10.1111/crj.13705.


Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma.

Hashimoto M, Yuki M, Kitajima K, Fukuda A, Nakamichi T, Nakamura A Cancers (Basel). 2022; 14(18).

PMID: 36139517 PMC: 9497080. DOI: 10.3390/cancers14184356.


In pursuit of the primary.

Mendonca J, Acharya V, Dsouza S, Sahu K, Kamath S, Kini J Breathe (Sheff). 2022; 17(4):210142.

PMID: 35296103 PMC: 8919789. DOI: 10.1183/20734735.0142-2021.


Architectural aspects of cell-blocks as small biopsies.

Satturwar S, Pantanowitz L Cytojournal. 2021; 18:5.

PMID: 33880128 PMC: 8053489. DOI: 10.25259/Cytojournal_4_2021.


Lateral decubitus chest radiography or chest ultrasound to predict pleural adhesions before medical thoracoscopy: a prospective study.

Thiam K, Guinde J, Laroumagne S, Bourinet V, Berbis J, Toure N J Thorac Dis. 2019; 11(10):4292-4297.

PMID: 31737314 PMC: 6837969. DOI: 10.21037/jtd.2019.09.54.


References
1.
Ishii H, Azuma K, Sakai K, Kawahara A, Yamada K, Tokito T . Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples. Oncotarget. 2015; 6(31):30850-8. PMC: 4741572. DOI: 10.18632/oncotarget.5068. View

2.
Sweeney B, Haq Z, Happel J, Weinstein B, Schneider D . Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer. 2005; 108(1):27-31. DOI: 10.1002/cncr.21425. View

3.
Swiderek J, Morcos S, Donthireddy V, Surapaneni R, Jackson-Thompson V, Schultz L . Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest. 2009; 137(1):68-73. DOI: 10.1378/chest.09-0641. View

4.
Norimatsu Y, Ohsaki H, Masuno H, Kagawa A, Teramoto N, Kobayashi T . Efficacy of CytoLyt® hemolytic action on ThinPrep® LBC using cultured osteosarcoma cell line LM8. Acta Cytol. 2013; 58(1):76-82. DOI: 10.1159/000354960. View

5.
Kern W, Haber H . Fine needle aspiration minibiopsies. Acta Cytol. 1986; 30(4):403-8. View